Utrecht University is one of the backers for biopharma firm Cristal Therapeutics.
Netherlands-based biopharmaceutical firm Cristal Therapeutics has raised €6m ($7.5m) to take its therapies for cancer and other diseases to clinical trials.
Utrecht University, the institution which spun-out Cristal and an existing backer, was one of the backers in the round. Venture capitalist Chemelot Ventures joins as a new investor, along with previous backers Thuja Capital, BioGeneration Ventures, Nedermaas, and Beheer Innovatiefonds Provincie Limburg, the innovation fund for the Province of Limburg.
Also announced with the round was the promotion of…
